Table of Content



Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Lung Cancer Screening Software Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Thousands)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Lung Cancer Screening Software Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Lung Cancer Screening Software Market: Regional Estimates & Trend Analysis
4.1. Lung Cancer Screening Software Market Share, By Region, 2023 & 2030, USD Thousands
4.2. North America
4.2.1. North America Lung Cancer Screening Software Market Estimates and Forecasts, 2018 - 2030 (USD Thousands)
4.2.2. U.S.
4.2.2.1. U.S. Lung Cancer Screening Software Market Estimates and Forecasts, 2018 - 2030 (USD Thousands)
4.2.3. Canada
4.2.3.1. Canada Lung Cancer Screening Software Market Estimates and Forecasts, 2018 - 2030 (USD Thousands)
4.2.4. Mexico
4.2.4.1. Mexico Lung Cancer Screening Software Market Estimates and Forecasts, 2018 - 2030 (USD Thousands)
4.3. Europe
4.3.1. Europe Lung Cancer Screening Software Market Estimates and Forecasts, 2018 - 2030 (USD Thousands)
4.3.2. U.K.
4.3.2.1. U.K. Lung Cancer Screening Software Market Estimates and Forecasts, 2018 - 2030 (USD Thousands)
4.3.3. Germany
4.3.3.1. Germany Lung Cancer Screening Software Market Estimates and Forecasts, 2018 - 2030 (USD Thousands)
4.3.4. France
4.3.4.1. France Lung Cancer Screening Software Market Estimates and Forecasts, 2018 - 2030 (USD Thousands)
4.3.5. Spain
4.3.5.1. Spain Lung Cancer Screening Software Market Estimates and Forecasts, 2018 - 2030 (USD Thousands)
4.3.6. Italy
4.3.6.1. Italy Lung Cancer Screening Software Market Estimates and Forecasts, 2018 - 2030 (USD Thousands)
4.3.7. Russia
4.3.7.1. Russia Lung Cancer Screening Software Market Estimates and Forecasts, 2018 - 2030 (USD Thousands)
4.4. Asia Pacific
4.4.1. Asia Pacific Lung Cancer Screening Software Market Estimates and Forecasts, 2018 - 2030 (USD Thousands)
4.4.2. China
4.4.2.1. China Lung Cancer Screening Software Market Estimates and Forecasts, 2018 - 2030 (USD Thousands)
4.4.3. Japan
4.4.3.1. Japan Lung Cancer Screening Software Market Estimates and Forecasts, 2018 - 2030 (USD Thousands)
4.4.4. Australia
4.4.4.1. Australia Lung Cancer Screening Software Market Estimates and Forecasts, 2018 - 2030 (USD Thousands)
4.5. Latin America
4.5.1. Latin America Lung Cancer Screening Software Market Estimates and Forecasts, 2018 - 2030 (USD Thousands)
4.5.2. Brazil
4.5.2.1. Brazil Lung Cancer Screening Software Market Estimates and Forecasts, 2018 - 2030 (USD Thousands)
4.6. Middle East and Africa
4.6.1. Middle East and Africa Lung Cancer Screening Software Market Estimates and Forecasts, 2018 - 2030 (USD Thousands)
4.6.2. South Africa
4.6.2.1. South Africa Lung Cancer Screening Software Market Estimates and Forecasts, 2018 - 2030 (USD Thousands)
Chapter 5. Competitive Landscape
5.1. Recent Developments & Impact Analysis by Key Market Participants
5.2. Company Categorization
5.3. Company Heat Map Analysis
5.4. Company Profiles
5.4.1. Nuance Communications, Inc.
5.4.1.1. Participant’s Overview
5.4.1.2. Financial Performance
5.4.1.3. Product Benchmarking
5.4.1.4. Recent Developments/ Strategic Initiatives
5.4.2. MRS
5.4.2.1. Participant’s Overview
5.4.2.2. Financial Performance
5.4.2.3. Product Benchmarking
5.4.2.4. Recent Developments/ Strategic Initiatives
5.4.3. Voxel Cloud
5.4.3.1. Participant’s Overview
5.4.3.2. Financial Performance
5.4.3.3. Product Benchmarking
5.4.3.4. Recent Developments/ Strategic Initiatives
5.4.4. Eon
5.4.4.1. Participant’s Overview
5.4.4.2. Financial Performance
5.4.4.3. Product Benchmarking
5.4.4.4. Recent Developments/ Strategic Initiatives
5.4.5. Koninklijke Philips N.V.
5.4.5.1. Participant’s Overview
5.4.5.2. Financial Performance
5.4.5.3. Product Benchmarking
5.4.5.4. Recent Developments/ Strategic Initiatives
5.4.6. Siemens Healthineers AG
5.4.6.1. Participant’s Overview
5.4.6.2. Financial Performance
5.4.6.3. Product Benchmarking
5.4.6.4. Recent Developments/ Strategic Initiatives
5.4.7. PENRAD
5.4.7.1. Participant’s Overview
5.4.7.2. Financial Performance
5.4.7.3. Product Benchmarking
5.4.7.4. Recent Developments/ Strategic Initiatives
5.4.8. MagView
5.4.8.1. Participant’s Overview
5.4.8.2. Financial Performance
5.4.8.3. Product Benchmarking
5.4.8.4. Recent Developments/ Strategic Initiatives
5.4.9. FUJIFILM Holdings Corporation
5.4.9.1. Participant’s Overview
5.4.9.2. Financial Performance
5.4.9.3. Product Benchmarking
5.4.9.4. Recent Developments/ Strategic Initiatives
5.4.10. Medtronic
5.4.10.1. Participant’s Overview
5.4.10.2. Financial Performance
5.4.10.3. Product Benchmarking
5.4.10.4. Recent Developments/ Strategic Initiatives